27870908|t|N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for Loss of Muscle Mass in Prevalent Hemodialysis Patients
27870908|a|Protein-energy wasting (PEW) is common in hemodialysis (HD) patients. A recent study demonstrated that a high level of N-terminal pro-B-type natriuretic peptide (NT-proBNP) may be associated with PEW in those patients. This prospective study aimed to assess the association of NT-proBNP with body composition and muscle loss. A cohort of prevalent HD patients (n = 238) was examined. Blood samples were obtained at baseline to measure high-sensitive C-reactive protein (hsCRP), interleukin-6 (IL-6), adiponectin and NT-proBNP. Nutritional status and changes in muscle mass were assessed by subjective global assessment, percentage creatinine generation rate (%CGR), creatinine index (CI) and lean body mass (LBM) estimated by dual-energy X-ray absorptiometry (DXA). The %CGR and CI were calculated five times for one year, and DXA was performed at baseline and one year later. Cardiac function was estimated by ultrasonography at baseline. NT-proBNP was significantly higher in HD patients with PEW. High NT-proBNP was associated with cardiac dysfunction, increased levels of hsCRP and IL-6, and serially decreased levels of the indexes for muscle mass. Multiple regression analysis adjusted with confounders showed that NT-proBNP was an independent predictor for decrease in LBM and serial lower levels of %CGR and CI. In conclusion, the present study demonstrated a novel association between NT-proBNP and muscle loss. NT-proBNP may be an independent biomarker for malnutrition in HD patients, especially in patients with muscles loss, regardless of chronic inflammation, cardiac dysfunction, or overhydration.
27870908	0	41	N-Terminal Pro-B-Type Natriuretic Peptide	T116,T123	C0754710
27870908	47	56	Biomarker	T201	C0005516
27870908	61	80	Loss of Muscle Mass	T046	C0026846
27870908	84	93	Prevalent	T081	C0220900
27870908	94	106	Hemodialysis	T061	C0019004
27870908	107	115	Patients	T101	C0030705
27870908	116	138	Protein-energy wasting	T047	C0012634
27870908	140	143	PEW	T047	C0012634
27870908	158	170	hemodialysis	T061	C0019004
27870908	172	174	HD	T061	C0019004
27870908	176	184	patients	T101	C0030705
27870908	195	200	study	T062	C2603343
27870908	221	225	high	T080	C0205250
27870908	226	231	level	T080	C0441889
27870908	235	276	N-terminal pro-B-type natriuretic peptide	T116,T123	C0754710
27870908	278	287	NT-proBNP	T116,T123	C0754710
27870908	296	311	associated with	T080	C0332281
27870908	312	315	PEW	T047	C0012634
27870908	325	333	patients	T101	C0030705
27870908	340	357	prospective study	T062	C1709709
27870908	367	373	assess	T058	C0184514
27870908	378	389	association	T080	C0439849
27870908	393	402	NT-proBNP	T116,T123	C0754710
27870908	408	424	body composition	T032	C0005885
27870908	429	440	muscle loss	T046	C0026846
27870908	444	450	cohort	T098	C0599755
27870908	454	463	prevalent	T081	C0220900
27870908	464	466	HD	T061	C0019004
27870908	467	475	patients	T101	C0030705
27870908	500	513	Blood samples	T031	C0178913
27870908	531	539	baseline	T081	C1442488
27870908	543	550	measure	T081	C0079809
27870908	551	584	high-sensitive C-reactive protein	T116,T129	C0006560
27870908	586	591	hsCRP	T116,T129	C0006560
27870908	594	607	interleukin-6	T116,T129	C0021760
27870908	609	613	IL-6	T116,T129	C0021760
27870908	616	627	adiponectin	T116,T123	C0389071
27870908	632	641	NT-proBNP	T116,T123	C0754710
27870908	643	661	Nutritional status	T033	C0392209
27870908	666	673	changes	T169	C0392747
27870908	677	688	muscle mass	T033	C0240417
27870908	694	702	assessed	T052	C1516048
27870908	706	734	subjective global assessment	T170	C0451514
27870908	808	822	lean body mass	T201	C0424678
27870908	824	827	LBM	T201	C0424678
27870908	842	874	dual-energy X-ray absorptiometry	T060	C1510486
27870908	876	879	DXA	T060	C1510486
27870908	903	913	calculated	T052	C1441506
27870908	933	937	year	T079	C0439234
27870908	943	946	DXA	T060	C1510486
27870908	964	972	baseline	T081	C1442488
27870908	981	985	year	T079	C0439234
27870908	986	991	later	T079	C0205087
27870908	993	1009	Cardiac function	T042	C0232164
27870908	1027	1042	ultrasonography	T060	C0041618
27870908	1046	1054	baseline	T081	C1442488
27870908	1056	1065	NT-proBNP	T116,T123	C0754710
27870908	1084	1090	higher	T080	C0205250
27870908	1094	1096	HD	T061	C0019004
27870908	1097	1105	patients	T101	C0030705
27870908	1111	1114	PEW	T047	C0012634
27870908	1116	1120	High	T080	C0205250
27870908	1121	1130	NT-proBNP	T116,T123	C0754710
27870908	1135	1150	associated with	T080	C0332281
27870908	1151	1170	cardiac dysfunction	T033	C3277906
27870908	1172	1197	increased levels of hsCRP	T033	C1963867
27870908	1202	1206	IL-6	T033	C0877589
27870908	1221	1230	decreased	T081	C0205216
27870908	1231	1237	levels	T080	C0441889
27870908	1245	1252	indexes	T170	C0600653
27870908	1257	1268	muscle mass	T033	C0240417
27870908	1270	1298	Multiple regression analysis	T080	C0681923
27870908	1313	1324	confounders	T169	C0009673
27870908	1337	1346	NT-proBNP	T116,T123	C0754710
27870908	1354	1365	independent	T078	C0085862
27870908	1366	1375	predictor	T078	C2698872
27870908	1380	1388	decrease	T081	C0547047
27870908	1392	1395	LBM	T201	C0424678
27870908	1407	1412	lower	T080	C0205251
27870908	1413	1419	levels	T080	C0441889
27870908	1463	1468	study	T062	C2603343
27870908	1484	1489	novel	T080	C0205314
27870908	1490	1501	association	T080	C0439849
27870908	1510	1519	NT-proBNP	T116,T123	C0754710
27870908	1524	1535	muscle loss	T046	C0026846
27870908	1537	1546	NT-proBNP	T116,T123	C0754710
27870908	1557	1568	independent	T078	C0085862
27870908	1569	1578	biomarker	T201	C0005516
27870908	1583	1595	malnutrition	T047	C0162429
27870908	1599	1601	HD	T061	C0019004
27870908	1602	1610	patients	T101	C0030705
27870908	1626	1634	patients	T101	C0030705
27870908	1640	1652	muscles loss	T046	C0026846
27870908	1668	1688	chronic inflammation	T046	C0021376
27870908	1690	1709	cardiac dysfunction	T033	C3277906
27870908	1714	1727	overhydration	T046	C0392689